Navigation Links
An Answer To Obesity: Weight Control Protein

Sometimes the answers to complex problems lies at hand but that is the place no one looks. Same is the case with a new anti obesity drug//. A weight control protein with a key role in the brain's ability to monitor body fat content may yield new approaches for treating obesity and type 2 diabetes.

The findings in mice further suggest that particular variants of the protein SH2-B might underlie obesity in humans, the researchers said. SH2-B, which has multiple functions in cells throughout the body, keeps the brain sensitive to the fat hormone leptin, found researchers from the University of Michigan Medical School. Produced by fat tissue, the leptin hormone sends signals to the brain about the body's fat content. That signal, in turn, elicits adjustments in appetite and energy expenditure to maintain normal body weight.

"Our findings reveal SH2-B as an important positive regulator of leptin sensitivity inside cells of the brain region known as the hypothalamus," said senior author of the study, Liangyou Rui. The hypothalamus is a key area in the central nervous system that integrates neuronal, hormonal, and nutrient-related signals to maintain body weight, he explained. Leptin is a hormone produced by fat that normally decreases food intake and increases energy expenditure. In many species, including humans, the hormone acts to stabilize weight and glucose balance through activating its receptors in the hypothalamus.

The current study shows that SH2-B also regulates energy balance and body weight by enhancing leptin sensitivity in animals, Rui said.

Further examination found that the animals lacking SH2-B ate nearly twice as much as normal. Surprisingly, Rui said, the animals burned more calories; however, the animals still have a net positive energy imbalance of more than 60% higher than normal animals at 18–19 weeks of age, owing to voracious feeding. The mice also exhibited defects in the leptin signaling pathway in b rain cells of the hypothalamus, they report.

The new findings reveal SH2-B as a critical component in maintaining leptin sensitivity, Rui said. Therefore, SH2-B and signaling events regulated by SH2-B may serve as potential therapeutic targets for the treatment of obesity and type 2 diabetes.

"Because SH2-B sensitizes both leptin and insulin, action drugs that mimic or enhance SH2-B action may improve insulin and leptin sensitivity and have potential value in treatment of obesity and type 2 diabetes," he added

This could be a giant step in the leap for anti- obesity drugs.

Source: University of Michigan
'"/>




Related medicine news :

1. Answer on SARS 3 to 4 weeks away
2. Answers For OCD soon
3. The Answer To Prevent Osteoporosis
4. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
5. Chronic Myelogenous Leukemia (CML) Has An Answer Now!
6. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
7. Emotional Engagement of Husband - A Final Answer To What Women Want
8. US Preparing To Answer Japans Queries On Beef Exports
9. Running Alone Might Not Be The Answer
10. Cancer Vaccine Could Serve As an Answer to Prevent Most of the Cancer
11. Tiny Easy Fitting Pump May Be The Answer For Major Open Heart Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... , ... September 20, 2017 , ... ... overcoming addiction. “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the creation ... background in the field of addiction and homeless services, including more than a ...
(Date:9/20/2017)... Texas (PRWEB) , ... September 20, 2017 , ... Houston, ... entire team took Friday, September 8, and Monday, September 11, off work and rolled ... Second Baptist Church before heading to local homes to start the process of rebuilding. ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “Psalms of Humidity”: ... peace of mind and move the readers one step closer to God. “Psalms of ... realized that his mistakes that have been made within his life are the very ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of ... Financial Favor of God; Second Edition” is the creation of published author, Brooks Rathell. ... this opportunity to talk to you about the financial favor of God. Not only ...
(Date:9/20/2017)... ... , ... “Monique”: is the story of Monique, whose mother’s deteriorating physical ... author, Colleen Crispi, has owned four beauty salons and written a book regarding the ... and cooking. , “The doctor’s office was only three blocks away, and she ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... -- Dealmed Medical Supplies, New York City,s ... drugs, vaccines, and specialty medical products and services, announced ... acquire Vantage Medical Supplies, a major distributor of medical ... York . ... practices, will operate under the Dealmed name as of ...
(Date:9/7/2017)... 2017 Caris Life Sciences, a leading ... promise of precision medicine, today announced results from ... its molecular profiling approach in guiding therapeutic strategies ... plus (CGP+) with Caris Molecular Intelligence ® ... molecular level, leading to more therapeutic options and ...
Breaking Medicine Technology: